Shaji Kumar, MD, a myeloma specialist from Mayo Clinic in Rochester, Minnesota, reviews recent updates in late-phase clinical trials for myeloma therapies, including selinexor, iberdomide, and novel combinations.
Shaji Kumar, MD, a myeloma specialist from Mayo Clinic in Rochester, Minnesota, reviews recent updates in late-phase clinical trials for myeloma therapies, including selinexor, iberdomide, and novel combinations.
